Background-In large mammals and humans, the contribution of I Ks to ventricular repolarization is still incompletely understood. Methods and Results-In vivo and cellular electrophysiological experiments were conducted to study I Ks in canine ventricular repolarization. In conscious dogs, administration of the selective I Ks blocker HMR 1556 (3, 10, or 30 mg/kg PO) caused substantial dose-dependent QT prolongations with broad-based T waves. In isolated ventricular myocytes under baseline conditions, however, I Ks block (chromanols HMR 1556 and 293B) did not significantly prolong action potential duration (APD) at fast or slow steady-state pacing rates. This was because of the limited activation of I Ks in the voltage and time domains of the AP, although at seconds-long depolarizations, the current was substantial. Isoproterenol increased and accelerated I Ks activation to promote APD 95 shortening. This shortening was importantly reversed by HMR 1556 and 293B. Quantitatively similar effects were obtained in ventricular-tissue preparations. Finally, when cellular repolarization was impaired by I Kr block, I Ks block exaggerated repolarization instability with further prolongation of APD. Conclusions-Ventricular repolarization in conscious dogs is importantly dependent on I Ks . I Ks function becomes prominent during ␤-adrenergic receptor stimulation, when it promotes AP shortening by increased activation, and during I Kr block, when it limits repolarization instability by time-dependent activation. Unstimulated I Ks does not contribute to cellular APD at baseline. These data highlight the importance of the synergism between an intact basal I Ks and the sympathetic nervous system in vivo.
I n large mammals and humans, the contribution of I Ks to the ventricular action potential (AP) is still unclear. In voltageclamp studies, I Ks appears as a large outward current during seconds-long depolarizing pulses. I Ks deficiencies in the human congenital long-QT (LQT) syndromes 1 and 5 and in the Jervell and Lange-Nielsen syndrome are often associated with abnormally long QT intervals. Acquired QT prolongation (eg, in cardiac hypertrophy or failure) is often attended by a downregulation of I Ks . 1, 2 Finally, some studies with the I Ks -blocking drug chromanol 293B (293B) show AP prolongation in the dog 3 and human. 4 Other studies, however, indicate that pharmacological I Ks block does not prolong canine ventricular AP durations (APDs) under baseline conditions. 5, 6 Also, in canine cardiac Purkinje cells, without ␤-adrenergic receptor stimulation, I Ks contributes little to repolarization. 7 Furthermore, in voltageclamped canine ventricular myocytes, I Ks is poorly activated during AP commands of normal duration. 5 Discussions on these data and their implications are vivid. 8, 9 Given these paradoxes in the understanding of I Ks , we combined in vivo and cellular electrophysiological experiments in dogs with the aim of better defining the importance of this K ϩ current for repolarization and to assess the usefulness of pharmacological I Ks block for delaying repolarization in vivo. University, Netherlands) and 6 beagle dogs (Center de Recherches Biologiques, Baugy, France) of either sex, weighing 12 to 37 kg, were used for the experiments.
In Vivo Studies With HMR 1556
For studies in conscious dogs (6 beagle dogs and 4 mongrel dogs), aliquots of the selective I Ks blocker HMR 1556 10, 11 were suspended in 0.5% hydroxyethylcellulose or packed in gelatin capsules and fed to the animals in the morning after overnight fasting. ECG monitoring was done with 24-hour Holter recordings or with telemetry transmitters and a computerized acquisition system (Data Science Inc). Concentrations of HMR 1556 in venous plasma were determined. (See Online Text Supplement 1.)
Cellular and Tissue Experiments
The procedure for isolating ventricular cells was the same as described earlier. 12 (See Online Text Supplement 2.) Myocytes were obtained from most of the transmural wall, except from a rim (1.5 mm) of epicardial and endocardial tissue. In separate experiments, transmural needle biopsies (Ϸ10ϫ1ϫ1 mm) were obtained from the left ventricular free wall for multicellular work. Experiments were performed at 37Ϯ1°C on a total of 83 cells and 4 biopsies from 35 dogs. (See Online Text Supplement 3.)
Statistics
The data are expressed as meanϮSEM. Intergroup comparisons were made with Student's t test for unpaired and paired data groups after testing for the normality of distribution. Multiple groups were analyzed by 1-way ANOVA. Differences were considered significant at a value of PϽ0.05.
Results

QT Prolongation by I Ks Block in Conscious Dogs
ECG changes on single oral administration of HMR 1556 at 3, 10, or 30 mg/kg were monitored in 10 conscious dogs. As shown in Figure 1 , HMR 1556 caused a substantial dosedependent prolongation of the QT c interval (Fridericia's formula) within 3 hours of administration. T waves were broad-based and asymmetrical and had an unaltered polarity under these conditions ( Figure 1B ). P-wave and QRScomplex morphology and PQ and QRS intervals did not change. Although most dogs tended to develop a slight drop in heart rate during HMR 1556, this effect was not statistically significant at any dose. After 30 mg/kg, the maximal measured plasma HMR-1556 concentration was 2.68Ϯ0.55 mol/L, providing full I Ks block (see below). Plasma concentrations returned to zero within 24 hours. 
I Ks Block by HMR 1556 and 293B
The cellular basis for in vivo QT prolongation by I Ks block was studied in isolated canine ventricular myocytes and multicellular preparations. HMR 1556 and 293B could fully block I Ks (Figure 2A ), because they inhibited all timedependent activating and tail currents. Concentrationresponse studies on I Ks tails ( Figure 2B ) confirmed that HMR 1556 is a more potent I Ks blocker than 293B. 10, 11 During AP recordings with high-resistance microelectrodes under baseline conditions, AP configurations remained unaltered at 3 and 10 mol/L 293B, but a slight loss of the notch occurred at 30 mol/L, consistent with I to inhibition. 13 Complete loss of the notch, triangulation of the AP, and aspecific APD responses were observed at 100 mol/L. No AP changes were observed with HMR 1556. In Figure 2C , the APD at 95% of repolarization (APD 95 ) is plotted against pacing cycle length (CL) during 30 mol/L 293B (ie, Ͼ3ϫIC 50 for I Ks block) and 500 nmol/L HMR 1556 (Ͼ7ϫIC 50 ).
Mean APDs remained unaltered at all CLs. Fast pacing-dependent shortening of the APD was maintained.
To directly compare I Ks and I Kr in individual cells, 293B-sensitive and almokalant-sensitive outward currents were examined during (APD-relevant) short depolarizations (V test ) of 300 ms. At normal external K ϩ concentration ([K ϩ ] o ), I Kr activation reached maximal amplitudes within tens of milliseconds, whereas I Ks became significant only at the end of 300-ms depolarizations. In Figure 3 , voltageand time-dependent activation of I Ks is shown for 31 cells in 0 [K ϩ ] o . The arrow indicates that at 300-ms duration, no significant I Ks is generated at voltage steps (V test ) Յ10 mV. However, at 3000-ms duration, it was 0.4Ϯ0.1 pA/pF in these same cells. The time course of full activation of I Ks could be measured during 5000-ms V test to 20 mV. Half-maximal activation time was 702Ϯ59 ms. Half-times for deactivation were voltage dependent and decreased from 333Ϯ27 ms on repolarization to Ϫ10 mV to only 40Ϯ5 ms at Ϫ80 mV, consistent with previous data. 12, 14 
I Ks Enhancement by ␤-Adrenergic Receptor Stimulation
I Ks was markedly enhanced by isoproterenol, consistent with previous reports. 7, 15 Figure 4 shows time-and voltagedependent activation during 100 nmol/L. Compared with baseline, half-maximal activation time decreased to 510Ϯ67 ms (PϽ0.05). Isoproterenol even enhanced I Ks during very short pulses of 100 ms when hardly any current had been measurable at baseline. Enhancement and acceleration modified I Ks such that for 300-ms pulses, significant current amplitudes were reached at V test equal to or more positive than Ϫ10 mV ( Figure 4B ). Enhanced I Ks was completely inhibited by 100 mol/L 293B ( Figure 4C ) or 500 nmol/L HMR 1556, indicating that the concentration-response curves of I Ks inhibition at baseline were not shifted to the right by moderate ␤-adrenergic receptor stimulation.
In AP recordings in single myocytes, isoproterenol (20 or 40 nmol/L) increased plateau V m by maximally 12 mV and prolonged APD at V m Ͼ0 mV. APD 95 , however, was shortened at these concentrations. 293B (10 and 30 mol/L) or HMR 1556 (100 and 500 nmol/L) partially reversed this shortening, most notably at slow pacing rates ( Figure 5 ). Invariably, the AP-prolonging effects of I Ks inhibition manifested at the end of the plateau, ie, Ͼ100 ms after the upstroke, resulting in prolongation of the APD 95 . During isoproterenol plus I Ks block, fast pacing-dependent shortening of the APD was maintained. These data indicated that ␤-adrenergic receptor stimulation enhanced I Ks directly and via favorable changes of the AP profile (increased plateau V m and longer APD at V m Ͼ0 mV).
I Ks Block During ␤-Adrenergic Receptor Stimulation in Ventricular Tissue
Given the possibility that I Ks channels of individual myocytes could have been damaged by the cell-isolation procedure, which could negatively influence the AP data, we repeated our experiments with isoproterenol plus HMR 1556 in ventricular multicellular preparations (nϭ4 dogs). Figure 6 shows that the AP data from a broad midmyocardial layer were very similar to the AP findings in myocytes ( Figure 5 ), confirming the importance of ␤-adrenergic receptor stimulation for I Ks in intact ventricular repolarization and ruling out a major negative influence of the enzymatic isolation procedure on I Ks in single cells.
Safety-Factor Role of I Ks When Repolarization Is Impaired by I Kr Block
Finally, we evaluated the effects of I Ks block after AP preprolongation with the I Kr blocker almokalant (1 mol/L; Figure 7 for CL 2000 ms) in single cells, assuming that during a longer AP, more I Ks is activated. Whereas 293B did not change the APD, almokalant increased it significantly, from 293Ϯ2 to 374Ϯ4 ms (ϩ28%) at CL 500 ms and from 353Ϯ2 to 813Ϯ21 ms (ϩ130%) at CL 2000 ms. The addition of 293B exaggerated the repolarization instability and further increased the APD from 374 to 398Ϯ19 ms and from 813 to 1120Ϯ100 ms at the same CLs (PϽ0.05 for both). Early afterdepolarizations were frequently seen under these circumstances. Similar observations were made at CL 1000 ms. Poincaré plots 16 of APD 95 (beat n/nϪ1; Figure 7C ) showed narrow clustering of the data points at baseline, increased deviations from the line yϭx during almokalant, and more complex polygons during almokalant plus 293B. These effects were reversible on washout.
Discussion
The results of the present study indicate that (1) I Ks is a major contributor to ventricular repolarization in conscious dogs;
(2) I Ks is most prominent during ␤-adrenergic receptor stimulation, when it promotes AP shortening by increased and accelerated activation, and during I Kr block, when it limits repolarization prolongation and instability by time-dependent activation; and (3) under baseline conditions in ventricular myocytes, adrenergically unstimulated I Ks does not contribute significantly to repolarization, because its activation is restrained by the voltage and time domains of the AP. manol HMR 1556 is probably the most selective for I Ks . Thomas et al 11 found an IC 50 for I Ks block of 11 nmol/L, whereas I Kr , I CaL , and I to were only half-maximally inhibited at 13, 28, and 34 mol/L, indicating Ͼ1000-fold selectivity. I K1 was unaffected at concentrations as large as 50 mol/L. In our hands, HMR 1556 blocked I Ks of canine ventricular myocytes half-maximally at 65 nmol/L.
I Ks Is a Major Contributor to Ventricular Repolarization in Conscious Dogs
Our in vivo results with HMR 1556 indicate that the QT interval can prolong quite dramatically by I Ks inhibition. QT responses were dose-dependent at 3, 10, and 30 mg/kg ( Figure  1 ). According to the selectivity data, at the highest oral dose of 30 mg/kg with a measured plasma concentration of 2.68Ϯ0.55 mol/L, the observed repolarization effects were largely a result of I Ks block, although a small contribution of I Kr block 11 cannot be excluded. At the lower dosages (3 and 10 mg/kg), the effects must be fully ascribed to the inhibition of I Ks with QT c prolongations of 11Ϯ1% and 34Ϯ5%, respectively.
Other investigators administered the benzodiazepinederived I Ks blocker L-768,673 (IC 50 ϭ6 nmol/L 17 ) to conscious dogs and found a dose-dependent QT prolongation of 5% to 15% at 0.03 to 1.0 mg/kg. 17 The oral bioavailability of L-768,673 in Methocell suspension was only 27%, and plasma concentrations were not reported. Therefore, we cannot compare these QT responses with our own findings. Bauer et al 18 reported on the effects of 10 mg/kg 293B in anesthetized dogs with acute complete atrioventricular block, demonstrating that ventricular effective refractory periods were prolonged at fast (CL 300 ms) and slow (CL 850 ms) pacing rates. In dogs with subacute myocardial infarction, 293B prolonged local effective refractory periods more in the infarct zone than in normal areas. 19 Unfortunately, no quantitative QT-interval or monophasic-APD data were provided. 
Volders et al I Ks in Canine Ventricular Repolarization
I Ks Becomes Prominent During I Kr Block and ␤-Adrenergic Receptor Stimulation
In Poincaré plots of prolonged APDs during I Kr block with almokalant, we noted an exaggeration of repolarization instability when 293B was also added. This strongly suggested that timedependent activation of I Ks is recruited when other influences cause excessive AP prolongation. 5, 20 Such a protective role would be enhanced during naturally stimulated or drug-induced I Ks increases. ␤-Adrenergic receptor stimulation increased and accelerated I Ks activation, so that it contributed significantly to AP shortening. Shimizu and Antzelevitch 3 provided the important insight that I Ks block combined with ␤-adrenergic receptor stimulation in canine left ventricular wedge preparations increases transmural dispersion of repolarization and can induce polymorphic tachyarrhythmias. These investigators reported homogeneous prolongations of transmural APDs by 293B, 3 which appears to be in contrast to our present finding that cellular APs were not prolonged at baseline (Figure 2 ). We assume that in ventricular wedge preparations, residual adrenergic activity remains present for a considerable time after excision of the tissue. For example, norepinephrine is progressively released after Ն5 to 10 minutes of no-flow ischemia and reperfusion in excised cardiac tissue of various species, including human 21 and dog. 22 This could mean that adrenergically stimulated, not basal, I Ks is inhibited in wedge preparations. 
Kinetics of I Ks Activation Preclude a Significant Contribution to Cellular Repolarization at Baseline
Among the known sarcolemmal K ϩ currents, I Ks has distinctively slow activation kinetics and a unique pharmacological responsiveness, ␤-adrenergic sensitivity, and regional myocardial distribution. In our recordings, I Ks appeared as a robust outward current during seconds-long depolarizations. Slow activation and rapid deactivation kinetics typically characterized it. At pulses to 20 mV, half-maximal activation was reached at Ϸ700 ms, with little current generated in the first 100 ms of depolarization. Accordingly, drug-induced I Ks inhibition did not prolong the cellular APD at baseline. Half-times for complete deactivation were as short as 40 ms at Ϫ80 mV (in line with Reference 14) . The recent demonstration of similar kinetics in human ventricular myocytes 23 underscores the clinical relevance of our data.
Clinical Implications
Pharmacological inhibition of I Ks by HMR 1556 in conscious dogs could be suitable as an in vivo model of the human congenital LQT 1 syndrome. Future studies could focus on the potential arrhythmogenic consequences of adrenergic challenges during exercise, excitement, or arousal from sleep in this model. Alternatively, the antiarrhythmic properties of ␤-blocking therapy, sympathetic ganglionectomy, or other modalities could be tested.
On the basis of the results of this study, the antiarrhythmic properties of I Ks blockers warrant further evaluation. Previous experiments with L-768,673 in exercising dogs with healed anterior-wall myocardial infarction and superimposed ischemia (transient occlusion of left circumflex coronary artery) demonstrated the efficacy of the drug against ventricular fibrillation, even at a modest 7% increase in QT c at baseline. 24 It is tempting to speculate that cardiac sympathetic activity was intense but dispersed during exercise and regional ischemia and that L-768,673 prevented arrhythmogenic dispersion of repolarization by attenuating adrenergically sensitive I Ks .
Finally, the present data indicate that the inhibition of I Ks under circumstances in which I Kr is already blocked or downregulated can cause an exaggeration of repolarization instability and AP prolongation, possibly leading to arrhythmias. 
Limitations
For our cellular experiments, we used myocytes from the transmural left ventricular free wall, except from a rim of epicardial and endocardial tissue. Thus, the layer from which the cells were isolated constitutes most of the transmural mass (Ն75%), so its contribution to global repolarization would be dominant. It might be argued that the exclusion of thin layers of epicardial and endocardial myocytes could bias our conclusion that I Ks does not contribute significantly to cellular APD under baseline conditions. However, the fact that I Ks shows a limited activation within the normal AP is primarily because of its kinetic characteristics (this study). These characteristics are similar in epicardial, midmyocardial, and endocardial myocytes, 25 indicating that even for the largest I Ks amplitudes that we found (often as large as the amplitudes of epicardial and endocardial myocytes reported by others 25 ), the contribution to repolarization is still limited.
The internal pipette solution for voltage-clamp experiments contained EGTA. One could argue that intracellular Ca 2ϩ buffering by EGTA influences Ca 2ϩ -dependent activation of I Ks and that this would bias the conclusion that I Ks does not contribute significantly to cellular APD under baseline conditions. However, (1) although EGTA buffers the bulk cytoplasmic Ca 2ϩ well, it fails to do so in the subsarcolemmal space. 26 Previously, it was shown that ionic currents dependent on subsarcolemmal Ca 2ϩ (eg, I CaL ) were not influenced by EGTA. 26 This would also apply to I Ks function; and (2) our AP recordings were obtained with high-resistance microelectrodes with no Ca 2ϩ buffer inside.
Conclusions
Both our in vivo and cellular data highlight the prominent role of I Ks in canine ventricular repolarization. I Ks limits excessive AP prolongation by time-dependent activation during I Kr block. ␤-Adrenergic receptor stimulation increases and accelerates I Ks activation to promote APD 95 shortening. The synergism between an intact basal I Ks and a balanced sympathetic nervous function promotes a short and homogeneous repolarization of the ventricles.
